These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 2650954

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mechanisms of renal anionic drug transport.
    El-Sheikh AA, Masereeuw R, Russel FG.
    Eur J Pharmacol; 2008 May 13; 585(2-3):245-55. PubMed ID: 18417112
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.
    Perri D, Ito S, Rowsell V, Shear NH.
    Can J Clin Pharmacol; 2003 May 13; 10(1):17-23. PubMed ID: 12687033
    [Abstract] [Full Text] [Related]

  • 5. Renal transport of drugs: specificity and molecular mechanisms.
    Somogyi A.
    Clin Exp Pharmacol Physiol; 1996 May 13; 23(10-11):986-9. PubMed ID: 8911747
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mechanisms and clinical implications of renal drug excretion.
    Masereeuw R, Russel FG.
    Drug Metab Rev; 2001 May 13; 33(3-4):299-351. PubMed ID: 11768771
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Renal transepithelial secretion of ochratoxin A in the non-filtering toad kidney.
    Bahnemann E, Kerling HP, Ensminger S, Schwerdt G, Silbernagl S, Gekle M.
    Toxicology; 1997 Jun 06; 120(1):11-7. PubMed ID: 9160104
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Principles and clinical application of assessing alterations in renal elimination pathways.
    Tett SE, Kirkpatrick CM, Gross AS, McLachlan AJ.
    Clin Pharmacokinet; 2003 Jun 06; 42(14):1193-211. PubMed ID: 14606929
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Kinetic studies on drug disposition in rabbits. I. Renal excretion of iodopyracet and sulfamethizole.
    Katayama K, Ohtani H, Kawabe T, Mizuno H, Endoh M, Kakemi M, Koizumi T.
    J Pharmacobiodyn; 1990 Feb 06; 13(2):97-107. PubMed ID: 2384854
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Carrier-mediated transport in the hepatic distribution and elimination of drugs, with special reference to the category of organic cations.
    Meijer DK, Mol WE, Müller M, Kurz G.
    J Pharmacokinet Biopharm; 1990 Feb 06; 18(1):35-70. PubMed ID: 2184216
    [Abstract] [Full Text] [Related]

  • 19. Tubular reabsorption of myo-inositol vs. that of D-glucose in rat kidney in vivo et situ.
    Silbernagl S, Völker K, Dantzler WH.
    Am J Physiol Renal Physiol; 2003 Jun 06; 284(6):F1181-9. PubMed ID: 12736166
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic implications of renal anionic drug transporters.
    Masereeuw R, Russel FG.
    Pharmacol Ther; 2010 May 06; 126(2):200-16. PubMed ID: 20227439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.